BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30678441)

  • 1. Protease Cargo in Circulating Exosomes of Breast Cancer and Ovarian Cancer Patients.
    Tamkovich SN; Yunusova NV; Tugutova E; Somov AK; Proskura KV; Kolomiets LA; Stakheeva MN; Grigor’eva AE; Laktionov PP; Kondakova IV
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):255-262. PubMed ID: 30678441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Exosomes of Patients with Breast and Ovarian Tumors Contain an Inactive 20S Proteasome.
    Yunusova N; Kolegova E; Sereda E; Kolomiets L; Villert A; Patysheva M; Rekeda I; Grigor'eva A; Tarabanovskaya N; Kondakova I; Tamkovich S
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between Tetraspanin- Associated and Tetraspanin- Non- Associated Exosomal Proteases and Metabolic Syndrome in Colorectal Cancer Patients.
    Tugutova EA; Tamkovich SN; Patysheva MR; Afanas’ev SG; Tsydenova AA; Grigor’eva AE; Kolegova ES; Kondakova IV; Yunusova NV
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):809-815. PubMed ID: 30909692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal Protease Cargo as Prognostic Biomarker in Colorectal Cancer.
    Yunusova NV; Zambalova EA; Patysheva MR; Kolegova ES; Afanas'ev SG; Cheremisina OV; Grigor'eva AE; Tamkovich SN; Kondakova IV
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):861-869. PubMed ID: 33773551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM.
    Runz S; Keller S; Rupp C; Stoeck A; Issa Y; Koensgen D; Mustea A; Sehouli J; Kristiansen G; Altevogt P
    Gynecol Oncol; 2007 Dec; 107(3):563-71. PubMed ID: 17900673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinases at the surface of small extrcellular vesicles in advanced ovarian cancer: Relationships with ascites volume and peritoneal canceromatosis index.
    Yunusova NV; Patysheva MR; Molchanov SV; Zambalova EA; Grigor'eva AE; Kolomiets LA; Ochirov MO; Tamkovich SN; Kondakova IV
    Clin Chim Acta; 2019 Jul; 494():116-122. PubMed ID: 30904547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomechanical sandwich assay for multiple cancer biomarkers in breast cancer cell-derived exosomes.
    Etayash H; McGee AR; Kaur K; Thundat T
    Nanoscale; 2016 Aug; 8(33):15137-41. PubMed ID: 27492928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage.
    Rupp AK; Rupp C; Keller S; Brase JC; Ehehalt R; Fogel M; Moldenhauer G; Marmé F; Sültmann H; Altevogt P
    Gynecol Oncol; 2011 Aug; 122(2):437-46. PubMed ID: 21601258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant defensin PvD
    Skalska J; Oliveira FD; Figueira TN; Mello ÉO; Gomes VM; McNaughton-Smith G; Castanho MARB; Gaspar D
    Nanoscale; 2019 Dec; 11(48):23366-23381. PubMed ID: 31793603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD24 in plasma, exosome and ovarian tissue samples of serous ovarian cancer patients.
    Soltész B; Lukács J; Szilágyi E; Márton É; Szilágyi Bónizs M; Penyige A; Póka R; Nagy B
    J Biotechnol; 2019 Jun; 298():16-20. PubMed ID: 30959137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours.
    Nagare RP; Sneha S; Sidhanth C; Roopa S; Murhekar K; Shirley S; Swaminathan R; Sridevi V; Ganesan TS
    Cancer Biomark; 2020; 28(3):397-408. PubMed ID: 32224528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of Tumor-Associated microRNAs and Tetraspanines from Exosomes of Plasma and Ascitic Fluids of Ovarian Cancer Patients.
    Yunusova N; Dzhugashvili E; Yalovaya A; Kolomiets L; Shefer A; Grigor'eva A; Tupikin A; Kondakova I; Tamkovich S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of ascites derived exosomes on the stemness and invasion ability of ovarian cancer stem-like cell].
    Chen SP; Xia YF; Jiang HH; Sun WY; Lou YH
    Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):349-357. PubMed ID: 34034422
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
    Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
    Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multispectral Optical Tweezers for Biochemical Fingerprinting of CD9-Positive Exosome Subpopulations.
    Carney RP; Hazari S; Colquhoun M; Tran D; Hwang B; Mulligan MS; Bryers JD; Girda E; Leiserowitz GS; Smith ZJ; Lam KS
    Anal Chem; 2017 May; 89(10):5357-5363. PubMed ID: 28345878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Analysis of Blood Exosomes from Healthy Females and Breast Cancer Patients Reveals an Association between Different Exosomal Bioactivity on Non-tumorigenic Epithelial Cell and Breast Cancer Cell Migration in Vitro.
    Tutanov O; Orlova E; Proskura K; Grigor'eva A; Yunusova N; Tsentalovich Y; Alexandrova A; Tamkovich S
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing Radiation Increases the Activity of Exosomal Secretory Pathway in MCF-7 Human Breast Cancer Cells: A Possible Way to Communicate Resistance against Radiotherapy.
    Jabbari N; Nawaz M; Rezaie J
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
    Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.